A Phase 3 Trial of ARRY-797 in Patients with LMNA A/C-Related Dilated Cardiomyopathy (DCM)

Trial Profile

A Phase 3 Trial of ARRY-797 in Patients with LMNA A/C-Related Dilated Cardiomyopathy (DCM)

Planning
Phase of Trial: Phase III

Latest Information Update: 18 Aug 2017

At a glance

  • Drugs ARRY 797 (Primary)
  • Indications Dilated cardiomyopathy
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Aug 2017 New trial record
    • 09 Aug 2017 According to an Array BioPharma media release, the company plans to initiate this trial later this year.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top